RxDoctor Payments Data

Elizabeth Gawey, MD

Dermatology · Oklahoma City, OKNPI 1942215900

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations.

$7,924in general payments, 2019–2025

Across 360 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$875
  • Pfizer$847
  • Novartis$746
  • Sanofi$538
  • Mayne Pharma Commercial LLC$488
  • Lilly USA, LLC$444
  • plus $4K from 30 others

What the payments were for

  • Food & beverage$7,72998%
  • Education$1952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,924 in reported general payments places this provider in the 70th percentile of 114 dermatology providers in Oklahoma.

See all dermatology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$164,234
Medicare patients
482
Services billed
2,934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil19$1,716
Clobetasol Propionate25$1,423
Alclometasone Dipropionate31$673
Spironolactone19$570
Triamcinolone Acetonide66$458
Clindamycin Phosphate15$444
Doxycycline Hyclate15$241
ValacyclovirValacyclovir Hcl11$224
Mupirocin30$207
Terbinafine Hcl11$167

Paid to pharmacies, not to this prescriber.

Other dermatology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →